Related Experiment Video
Updated: Nov 10, 2025

06:40
Biofunctionalization of Magnetic Nanomaterials
Published on: July 16, 2020
2.8K
Superparamagnetic α-Fe2O3/Fe3O4 Heterogeneous Nanoparticles with Enhanced Biocompatibility
You Li1, Zhou Wang2, Ruijiang Liu1
1School of Pharmacy, Jiangsu University, Zhenjiang 212013, China.
Nanomaterials (Basel, Switzerland)
|April 3, 2021
Summary
Novel magnetic iron oxide nanoparticles (α-Fe2O3/Fe3O4) were synthesized. These nanoparticles demonstrated excellent biocompatibility and safety in preliminary cell and animal studies, indicating potential for biomedical applications.
Area of Science:
- Materials Science
- Nanotechnology
- Biomedical Engineering
Background:
- Development of novel magnetic nanoparticles is crucial for advanced applications.
- Iron oxide nanoparticles offer unique magnetic properties and potential biocompatibility.
- Heterogeneous nanoparticles can combine properties of different materials.
Purpose of the Study:
- To synthesize and characterize novel magnetic α-Fe2O3/Fe3O4 heterogeneous nanoparticles.
- To investigate factors influencing the Fe3O4 content in these nanoparticles.
- To evaluate the biocompatibility and safety of these nanoparticles for potential biomedical use.
Main Methods:
- Facile solution combustion synthesis using ferric nitrate and urea.
- Characterization using X-ray Diffraction (XRD), Scanning Electron Microscopy (SEM), Transmission Electron Microscopy (TEM), and Vibrating Sample Magnetometry (VSM).
- Assessment of cell viability (CCK8 assay) on human hepatocytes (L-02) and in vivo safety evaluation in mice.
Main Results:
- The ratio of ferric nitrate to urea was identified as a key factor controlling Fe3O4 content.
- Calcination temperature and time also influenced Fe3O4 content, allowing for tunable synthesis.
- α-Fe2O3/Fe3O4 nanoparticles showed no cytotoxicity to L-02 cells below 100 ng/mL.
- A tail vein administration dose of 0.9 mg/kg exhibited good biological safety in mice.
Conclusions:
- A facile method for preparing magnetic α-Fe2O3/Fe3O4 heterogeneous nanoparticles was established.
- Synthesis parameters can be optimized to control nanoparticle composition.
- These nanoparticles exhibit promising biocompatibility and safety profiles, supporting their potential for biomedical applications.

